No between-group differences were observed for reperfusion success and mortality, among other measures.
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
New research from the American Heart and American Stroke Associations found that many Americans don't know the symptoms of stroke.
The relative risk of developing ischemic stroke was increased in patients with systemic lupus erythematosus, especially within the first year after diagnosis.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
Over 32% of patients were functionally independent at 90 days and 37.1% were functionally independent at 2 years.
Pulse pressure was associated with the risk for ischemic stroke in first-ever ischemic stroke patients old than 60 years.
Previous research had suggested that the benefits of IV tPA are diminished in patients weighing more than 100 kg.
Up to 20% of stroke cases in young adults occur in those with cervical artery dissection, the leading cause of stroke in this population.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.
The results provide good evidence for the use of contact aspiration in ischemic stroke.
Delays related to the determination of treatment eligibility increased door-to-needle times by more than 30 minutes compared with patients with no delays.
Neither lying flat nor sitting up appears to alter outcomes in patients presenting with acute stroke.
The difference in rate of recurrence of PCAIS may have to do with a difference in mechanism compared with ACAIS.
Use of advanced imaging may help predict which patients will have an optimal response to treatment with intravenous tissue plasminogen activator.
Migraine affects approximately 20% of the general population and is associated with an increased risk for ischemic stroke.
Intravenous thrombolysis prior to mechanical thrombectomy did not benefit patients with acute ischemic stroke due to a large vessel occlusion.
Warfarin protected against ischemic stroke, major bleeding, and all-cause mortality in patients who continued to take the drug after dementia diagnosis.
The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.
Women with a history of migraine headache had a more than 2-fold increased risk of stroke over a 6-year follow-up period.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Another class of antacids, H2 receptor antagonists, had no impact on stroke risk.
Serious adverse events, especially those requiring hospitalization, may indicate an elevated risk of stroke.
The neuroprotective effect was evident after at least 6 months of use.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Patients with acute ischemic stroke experienced less disability when treated with early endovascular thrombectomy.
Cerebral microbleeds increase the risk for symptomatic ICH after thrombolysis for acute ischemic stroke.
Being overweight may slightly lower chances for hemorrhagic stroke, the study found.
The Trevo devices are the first to be indicated for use in conjunction with IV tPA.
Neurology Advisor Articles
- Serum Cytokine Levels May Correlate With Cognitive Dysfunction in Alzheimer's Disease
- Migraine-Associated Stroke Not Linked to Atherosclerosis
- Ptosis Repair Effective for Reducing Tension-Type Headache
- Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes
- MRI-Guided Focused Ultrasound More Cost Effective Treatment for Essential Tremor
- In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
- Stroke and Dementia Associated with Artificially-Sweetened Drinks?
- Case Report: DBS for the Treatment of Dystonia in Huntington's
- Treating Movement Disorders With Telemedicine: Getting Started
- Poor Quality of Sleep, Quality of Life in Patients With Lupus